BIOMATERIALS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2024-06-13 ms7000000914996124 来自四川省

审稿速度:1.0
偏重的研究方向：转化医学
经验分享：无

104 0

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2024-05-28 ms7000000914996124 来自四川省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：无

107 0

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2024-05-27 ms7000000914996124

wu

102 0

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2023-03-15 ms1000001648237989 来自浙江省

1.30submitted
1.31with editor
至今已43天了还是with editor

244 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2023-04-08 ms3000001204830531 来自浙江省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：生物材料;药剂学
经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！

235 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2019-10-13 ms391324488810565

审稿速度:3.0
经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？

249 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2023-02-21 ms8000001256930585 来自北京

一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈

282 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2023-04-03 ms2000002111376254 来自天津

审稿速度:24.0 | 投稿命中率:5.0
经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！

228 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2023-03-27 ms5000001146495904 来自湖北省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤治疗
经验分享：With editor58天被拒稿，都没送审，投稿慎重啊

293 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2209681, encodeId=9a9d2209681a8, content=审稿速度:1.0 偏重的研究方向：转化医学 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Thu Jun 13 14:28:56 CST 2024, time=2024-06-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2207000, encodeId=bc37220e000d3, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Tue May 28 12:12:26 CST 2024, time=2024-05-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2206801, encodeId=7eee2206801d4, content=wu , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59f79071994, createdName=ms7000000914996124, createdTime=Mon May 27 11:19:23 CST 2024, time=2024-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119514, encodeId=c76a2119514d4, content=1.30submitted 1.31with editor 至今已43天了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50668542940, createdName=ms1000001648237989, createdTime=Wed Mar 15 13:33:40 CST 2023, time=2023-03-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2124448, encodeId=dbf321244481e, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物材料;药剂学 经验分享：毕业生b i om a t e r i a ls一定要避开！！！去年11月中旬我投了该杂志，首先“with editor”这个状态显示了两个月，之后“under review”状态又两个月（可以审稿人过春节又耽误了），“review compeleted”一个月，今年3月底被拒，觉得我的文章配不上他们杂志，我真的会屑，作为毕业生，看不上我的文章，我不怪他们，是我写得差，拖了我五个月真的让我伤心。我真的被气到了，投这个杂志，尤其是毕业生，一定要慎重！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=770a8449444, createdName=ms3000001204830531, createdTime=Sat Apr 08 14:56:43 CST 2023, time=2023-04-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=854236, encodeId=65fe85423681, content=审稿速度:3.0 经验分享：投稿两周了，还是处于submitted tojournal 状态，作为一个top期刊，这个速度实在不应该啊。请教各位有投稿经验的同行，这种情况可不可以写信问下情况？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b62f5414001, createdName=ms391324488810565, createdTime=Sun Oct 13 10:53:41 CST 2019, time=2019-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115813, encodeId=205d211581336, content=一直with editor到48天拒稿，理由是我们会拒85%的稿，今年6月毕业硬生生被耽误1个半月，真诚建议毕业生们谨慎考虑哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e38519525, createdName=ms8000001256930585, createdTime=Tue Feb 21 22:15:05 CST 2023, time=2023-02-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2123369, encodeId=137b21233698c, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：with editor 50天被拒，模板拒，硬生生耽误了两个月，真心伤不起，以后坚决不投不引这个期刊！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b226489510, createdName=ms2000002111376254, createdTime=Mon Apr 03 09:07:27 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2122011, encodeId=1cd1212201114, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤治疗 经验分享：With editor58天被拒稿，都没送审，投稿慎重啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ca05579752, createdName=ms5000001146495904, createdTime=Mon Mar 27 08:58:40 CST 2023, time=2023-03-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2122776, encodeId=3a432122e7680, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：从来没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44158613319, createdName=ms5000000924184379, createdTime=Thu Mar 30 16:48:02 CST 2023, time=2023-03-30, status=1, ipAttribution=澳门)]

2023-03-30 ms5000000924184379 来自澳门

审稿速度:12.0 | 投稿命中率:5.0
经验分享：从来没送审

234 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务